Filter
81
Filtered Results: 81
Text search:
G.
Ravasi
Featured
Recommendations
8
New Publications
16
Language
Document type
No document type
38
Guidelines
20
Studies & Reports
19
Manuals
2
Situation Updates
1
Strategic & Response Plan
1
Countries / Regions
Indonesia
10
Latin America and the Carribbean
6
Global
4
Nepal
3
Nigeria
3
India
3
South Africa
2
Brazil
2
Ukraine
1
Ghana
1
Sierra Leone
1
Syria
1
Peru
1
Malawi
1
Zimbabwe
1
Guinea
1
Mozambique
1
Haiti
1
Asia
1
Tanzania
1
Congo, Democratic Republic of
1
Eastern Europe and Central Asia
1
Western and Central Europe
1
Paraguay
1
North America
1
Bangladesh
1
Uganda
1
Yemen
1
Ethiopia
1
Zambia
1
Liberia
1
Madagascar
1
Authors & Publishers
Publication Years
Category
Disaster Preparedness
6
COVID-19
6
Guidelines
6
Policies
5
Drugs & Medical Equipment
5
Studies & Reports
5
Policies & Guidelines HIV & TB
4
HIV & STI
4
Humanitarian Crisis
3
Humanitarian Aid
2
Non-communicable Diseases
2
Reproductive Health
2
Communicable Diseases
1
Diabetes
1
Countries
1
Health System Strengthening
1
Clinical Guidelines
1
Information, Education and Communication (IEC)
1
Disabilities
1
Capacity Building
1
Other
1
WASH
1
Immunization
1
Surgery & Anaesthesia
1
Primary Health Care
1
Age & Elderly
1
Global Health
1
Pharmacy & Technologies
1
Toolboxes
HIV testing & services
7
Assessment & Response
6
Country specific documents
5
ART Drug Resistance
4
Disaster Preparedness & Prevention
4
Latin America & the Carribean
4
Reports & Studies
4
General Reports
2
Treatment & Prevention
2
Children & Adolescents
2
Opportunistic Infections
2
Clinical Guidelines
2
Paediatrics
2
Climate Change General
2
Guiding documents and principles
2
AmR (Region of Americas)
2
Reports & Studies Children HIV
2
Disability Rights & Convention
1
HIV in Children and mental health
1
Surveillance
1
Plague Situation Reports
1
Clinical Aspects, Treatment & Prevention
1
Europe
1
Substance Use Disorders, Others
1
Human Rights, Stigma & Discrimination
1
Treatment Guidelines HIV
1
Drug resistance
1
Adherence
1
Health & Refugee
1
Stress
1
General
1
Situation Reports & Updates
1
Clinical Aspects
1
Scientific & Research Studies
1
General
1
Essential Medicines & Medical Devices
1
Advocacy & Communication
1
Overview
1
Reports
1
Advocacy
1
Essential Medicines
1
Surgery
1
General documents One Health
1
Disaster, Migration and Conflict
1
Situation Reports & Updates
1
Guidelines & Manuals
1
Antimicrobial Resistance (AMR)
1
Best Practice Examples
1
Education
1
Clinical Aspects & Diagnosis
1
Studies & Reports
1
Prevention & Strategies
1
General
1
Co-Morbidities (except TB)
1
Alzheimer's Disease & Dementia
1
Protection
1
Assessment & Response
1
National Emergency Response Plans
1
One Health
1
TB/HIV Global
1
Self-harm & Suicide
1
Assessment
1
Antiretroviral Treatment ART
1
Safe Burials
1
San José, Costa Rica, Noviembre 4–5 noviembre 2008
Global AIDS Update 2018
Closing Gaps
Breaking Barriers
Righting injustices
Combler les écarts
Rompre les barrières
Réparer les injustices
Synthèse
With this study, we estimated the burden of serious fungal infections for the general healthy population and for those at risk, including those infected with HIV, patients with asthma, as well as those under intensive care. We also highlight from studies in progress of high incidences of histoplasm...
Cryptococcal disease is one of the most common opportunistic infections among people living with advanced HIV disease and is a major contributor to severe illness, morbidity, and mortality, particularly in sub-Saharan Africa.
These guidelines update the recommendations that were first released i...
There is no secret to our procedure: the daily scanning of the literature helps us to stay afloat in the never-ending waves of new publications about SARS-CoV-2 and COVID-19. Many papers discussed in the Top 10 will eventually make it into subsequent editions of COVID Reference.
Guidance for General Medical and Specialised Mental Health Care Settings
WHO Living guideline: Drugs to prevent COVID-19
recommended
Interim guidance 2 march 2021
Current use of drugs to prevent COVID-19 is variable, reflecting large-scale uncertainty. Numerous randomized trials of many different drugs are underway to inform practice. This first version of the Drugs to prevent COVID-19: A WHO living guideline contains new inform...
El presente protocolo se aplica en las Instituciones Prestadoras de Servicios de Salud del Ministerio de Salud, a través de las Direcciones de Redes Integradas de Servicios de Salud y de los gobiernos regionales, a través de las Direcciones Regionales de Salud o Gerencias Regionales de Salud , EsS...
Updated Treatment Guidelines
Lancet Public health 2022 January 6, 2022 https://doi.org/10.1016/ S2468-2667(21)00249-8
Growth in the number of individuals living with dementia underscores the need for public health planning efforts and policy to address the needs of this group. Country-level estimates can be used to inform nati...
La tendencia al calentamiento en América Latina y el Caribe continuó en 2021. La tasa media de aumento de las temperaturas fue de aproximadamente 0,2 °C por década entre 1991 y 2021, en comparación con los 0,1 °C por década registrados entre 1961 y 1990.En 2021, la temperatura se situó por e...
The WHO Living guideline: Drugs to prevent COVID-19 contains the Organization’s most up-to-date recommendations for the use of drugs to prevent COVID-19. The latest version of this living guideline is available in pdf format (via the ‘Download’ button) and via an online platform.
Guidelines ...
Heart failure with a reduced ejection fraction (HFrEF) is a condition frequently encountered by healthcare professionals and, in order to achieve the best outcomes for patients, needs to be managed optimally. This guideline document is based on the European Society of Cardiology Guidelines for the t...
WHO has published the first-ever guidance on the clinical management of diphtheria. The only previously available guidance was an operational protocol. The new guidance followed the rigorous process for developing guidance at WHO.
It addresses the use of Diphtheria Antitoxin (DAT) in the treatmen...
The availability, prices and affordability of essential medicines in Malawi: A cross-sectional study
The Malawian government recently introduced cost-covering consultation fees for self-referral patients in tertiary public hospitals. Previously, patients received medicines free of charge in government-owned health facilities, but must pay elsewhere. Before the government implements a payment policy...
